新型炎症标志物预测伴嗜酸性粒细胞增多和全身症状的药物反应预后的模型开发与验证
这项国际多中心回顾性队列研究纳入台湾、新加坡和日本169例DRESS患者,评估新型炎症标志物与院内死亡率的关联,并开发验证风险分层模型。多因素分析发现低血红蛋白与红细胞分布宽度比值、高血小板与淋巴细胞比值及低单核细胞计数为死亡的显著预测因素,结合基础疾病的预测模型显示出良好区分度和可接受准确性。
要点
- 低血红蛋白与红细胞分布宽度比值、高血小板与淋巴细胞比值及低单核细胞计数是DRESS死亡的显著预测因素。
- 结合炎症标志物与基础疾病的预测模型对DRESS相关死亡具有良好区分度和可接受准确性。
- 该风险分层模型可能有助于DRESS严重程度分层和早期干预。
核心结论
- 新型炎症标志物与DRESS患者院内死亡率相关,基于这些标志物和基础疾病的风险分层模型可能有助于严重程度分层。
研究设计与样本
- 国际多中心回顾性队列研究,纳入台湾、新加坡和日本169例确诊DRESS患者,收集诊断后3天内的 demographics 和实验室标志物,采用逻辑回归和ROC曲线分析,并通过留一交叉验证进行内部验证。
主要发现
- 多因素分析显示低血红蛋白与红细胞分布宽度比值、高血小板与淋巴细胞比值和低单核细胞计数是死亡的显著预测因素。
- 结合显著炎症标志物和基础疾病(恶性肿瘤、自身免疫病和心血管疾病)的DRESS相关死亡预测模型显示出良好区分度和可接受准确性。
临床怎么用
- 临床可计算血红蛋白与红细胞分布宽度比值、血小板与淋巴细胞比值和单核细胞计数,结合基础疾病评估DRESS患者死亡风险,辅助早期干预决策。
局限性
- 回顾性设计、院间转院等因素以及基础恶性肿瘤是研究的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a life-threatening disease that has received little attention focusing on its prognostic markers. OBJECTIVE: We evaluated the association between novel inflammatory markers and in-hospital mortality. We also proposed and validated a risk stratification model to aid early intervention. METHODS: This international multicenter, retrospective cohort study included 169 patients diagnosed with DRESS from Taiwan, Singapore, and Japan, collecting demographics and laboratory markers within 3 days of diagnosing DRESS. Inflammatory markers were calculated, and statistical analyses, including logistic regression and receiver operating characteristic curve analysis. Predictive models were developed with internal validation using leave-one-out cross-validation. RESULTS: Lower hemoglobin-to-red blood cell distribution width ratio, higher platelet-to-lymphocyte ratio, and lower monocyte count are identified as significant predictors of mortality in a multivariate analysis. A predictive model for DRESS-related mortality, incorporating the significant inflammatory markers and underlying disease (malignancy, autoimmune disease, and cardiovascular disease), demonstrated good discrimination ability and acceptable accuracy. LIMITATION: The retrospective design, along with factors like interhospital transfers, and underlying malignancies are limitations. CONCLUSION: The presence of these novel inflammatory markers and the development of risk stratification model may be of value to stratification of the severity of DRESS.
引用
- Hsieh TS, Lee HY, Abe R, et al. Development and validation of prognostic models using novel inflammatory markers for drug reactions with eosinophilia and systemic symptoms: An international multicenter cohort study. J Am Acad Dermatol. 2025. PMID: 40663026. doi:10.1016/j.jaad.2025.06.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。